Cedric’ study (2020) demonstrated that circRNA-ZFR was highly expressed in HCC tumor tissues and cells, correlated with the poor prognosis of HCC patients, and circRNA-ZFR was also proved to promote tumor cells’ proliferative capacity by targeting MAP2K1. This evidence concerns the gene MAP2K1 and hepatocellular carcinoma.